Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-11

FDA Approved: NIFEDIPINE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for nifedipine from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

SUPPL AP for NIFEDIPINE (NIFEDIPINE)